Fraxiparin in Stroke Study "FISS"

Completed

Phase 3 Results

Summary of Purpose

To compare two dosages of low-molecular-weight heparin with placebo in the treatment of ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 7 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, placebo-controlled trial. 2750 patients were initially screened and 312 were randomized.

Contacts

Not available